Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Benedict Lucchesi

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Dogs
Rabbits

Disorders

Physiology

Anatomy

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Miller Douglas L; Dou Chunyan; Lucchesi Benedict R
Cardiac arrhythmia and injury induced in rats by burst and pulsed mode ultrasound with a gas body contrast agent.
Booth Erin Anne; Flint RaShonda Renee; Lucas Kathryn Louise; Knittel Andrea Kathleen; Lucchesi Benedict R
Estrogen protects the heart from ischemia-reperfusion injury via COX-2-derived PGI2.
Nieman M T; Burke F; Warnock M; Zhou Y; Sweigart J; Chen A; Ricketts D; Lucchesi B R; Chen Z; Di Cera E; Hilfinger J; Kim J S; Mosberg H I; Schmaier A H
Thrombostatin FM compounds: direct thrombin inhibitors - mechanism of action in vitro and in vivo.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Benedict Lucchesi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Miller Douglas L; Dou Chunyan; Lucchesi Benedict R
Cardiac arrhythmia and injury induced in rats by burst and pulsed mode ultrasound with a gas body contrast agent.
Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 2009;28(11):1519-26.
2008: Booth Erin Anne; Flint RaShonda Renee; Lucas Kathryn Louise; Knittel Andrea Kathleen; Lucchesi Benedict R
Estrogen protects the heart from ischemia-reperfusion injury via COX-2-derived PGI2.
Journal of cardiovascular pharmacology 2008;52(3):228-35.
2008: Nieman M T; Burke F; Warnock M; Zhou Y; Sweigart J; Chen A; Ricketts D; Lucchesi B R; Chen Z; Di Cera E; Hilfinger J; Kim J S; Mosberg H I; Schmaier A H
Thrombostatin FM compounds: direct thrombin inhibitors - mechanism of action in vitro and in vivo.
Journal of thrombosis and haemostasis : JTH 2008;6(5):837-45.
2008: Marchesi Marta; Booth Erin A; Rossoni Giuseppe; García Ricardo A; Hill Knut R; Sirtori Cesare R; Bisgaier Charles L; Lucchesi Benedict R
Apolipoprotein A-IMilano/POPC complex attenuates post-ischemic ventricular dysfunction in the isolated rabbit heart.
Atherosclerosis 2008;197(2):572-8.
2008: Hong Ting-Ting; Huang Jinbao; Barrett Terrance D; Lucchesi Benedict R
Effects of cyclooxygenase inhibition on canine coronary artery blood flow and thrombosis.
American journal of physiology. Heart and circulatory physiology 2008;294(1):H145-55.
2008: Booth Erin A; Lucchesi Benedict R
Estrogen-mediated protection in myocardial ischemia-reperfusion injury.
Cardiovascular toxicology 2008;8(3):101-13.
2008: Lauver D Adam; Driscoll Edward M; Lucchesi Benedict R
Disodium disuccinate astaxanthin prevents carotid artery rethrombosis and ex vivo platelet activation.
Pharmacology 2008;82(1):67-73.
2007: Booth Erin A; Lucchesi Benedict R
Medroxyprogesterone acetate prevents the cardioprotective and anti-inflammatory effects of 17beta-estradiol in an in vivo model of myocardial ischemia and reperfusion.
American journal of physiology. Heart and circulatory physiology 2007;293(3):H1408-15.
2007: Booth Erin A; Marchesi Marta; Knittel Andrea K; Kilbourne Edward J; Lucchesi Benedict R
The pathway-selective estrogen receptor ligand WAY-169916 reduces infarct size after myocardial ischemia and reperfusion by an estrogen receptor dependent mechanism.
Journal of cardiovascular pharmacology 2007;49(6):401-7.
2006: Hong Ting-Ting; Huang Jinbao; Driscoll Edward; Lucchesi Benedict R
Preclinical evaluation of S18886 in an experimental model of coronary arterial thrombosis.
Journal of cardiovascular pharmacology 2006;48(5):239-48.
2006: Miller Douglas L; Driscoll Edward M; Dou Chunyan; Armstrong William F; Lucchesi Benedict R
Microvascular permeabilization and cardiomyocyte injury provoked by myocardial contrast echocardiography in a canine model.
Journal of the American College of Cardiology 2006;47(7):1464-8.
2006: Hong Ting-Ting; Huang Jinbao; Lucchesi Benedict R
Effect of thrombolysis on myocardial injury: recombinant tissue plasminogen activator vs. alfimeprase.
American journal of physiology. Heart and circulatory physiology 2006;290(3):H959-67.
2006: Lauver D Adam; Lucchesi Benedict R
Sulodexide: a renewed interest in this glycosaminoglycan.
Cardiovascular drug reviews 2006;24(3-4):214-26.
2006: Hennan James K; Driscoll Edward M; Barrett Terrance D; Fischbach Peter S; Lucchesi Benedict R
Effect of sodium/hydrogen exchange inhibition on myocardial infarct size after coronary artery thrombosis and thrombolysis.
Pharmacology 2006;78(1):27-37.
2006: Hong Ting-Ting; Van Gorp Cornelius L; Cardin Alan D; Lucchesi Benedict R
Intimatan (dermatan 4,6-O-disulfate) prevents rethrombosis after successful thrombolysis in the canine model of deep vessel wall injury.
Thrombosis research 2006;117(3):333-42.
2005: Booth Erin A; Obeid Nabeel R; Lucchesi Benedict R
Activation of estrogen receptor-alpha protects the in vivo rabbit heart from ischemia-reperfusion injury.
American journal of physiology. Heart and circulatory physiology 2005;289(5):H2039-47.
2005: Hong Ting-Ting; Huang Jinbao; Driscoll Edward; Lucchesi Benedict R
The antithrombotic effect of melagatran in combination with clopidogrel and/or aspirin (carotid artery primary thrombosis study).
Journal of cardiovascular pharmacology 2005;46(4):526-33.
2005: Lauver D Adam; Lockwood Samuel F; Lucchesi Benedict R
Disodium Disuccinate Astaxanthin (Cardax) attenuates complement activation and reduces myocardial injury following ischemia/reperfusion.
The Journal of pharmacology and experimental therapeutics 2005;314(2):686-92.
2005: Rodríguez Manuel; Cai Wei-Jun; Kostin Sawa; Lucchesi Benedict R; Schaper Jutta
Ischemia depletes dystrophin and inhibits protein synthesis in the canine heart: mechanisms of myocardial ischemic injury.
Journal of molecular and cellular cardiology 2005;38(5):723-33.
2005: Hong Ting-Ting; White Andrew J; Lucchesi Benedict R
Dermatan disulfate (Intimatan) prevents complement-mediated myocardial injury in the human-plasma-perfused rabbit heart.
International immunopharmacology 2005;5(2):381-91.
2005: Lauver D Adam; Booth Erin A; White Andrew J; Poradosu Enrique; Lucchesi Benedict R
Sulodexide attenuates myocardial ischemia/reperfusion injury and the deposition of C-reactive protein in areas of infarction without affecting hemostasis.
The Journal of pharmacology and experimental therapeutics 2005;312(2):794-800.
2004: Marchesi Marta; Booth Erin A; Davis Treasa; Bisgaier Charles L; Lucchesi Benedict R
Apolipoprotein A-IMilano and 1-palmitoyl-2-oleoyl phosphatidylcholine complex (ETC-216) protects the in vivo rabbit heart from regional ischemia-reperfusion injury.
The Journal of pharmacology and experimental therapeutics 2004;311(3):1023-31.
2004: Nieman Marvin T; Warnock Mark; Hasan Ahmed A K; Mahdi Fakhri; Lucchesi Benedict R; Brown Nancy J; Murphey Laine J; Schmaier Alvin H
The preparation and characterization of novel peptide antagonists to thrombin and factor VIIa and activation of protease-activated receptor 1.
The Journal of pharmacology and experimental therapeutics 2004;311(2):492-501.
2004: Fischbach Peter S; White Andrew; Barrett Terrance D; Lucchesi Benedict R
Risk of ventricular proarrhythmia with selective opening of the myocardial sarcolemmal versus mitochondrial ATP-gated potassium channel.
The Journal of pharmacology and experimental therapeutics 2004;309(2):554-9.
2003: Booth Erin A; Marchesi Marta; Kilbourne Edward J; Lucchesi Benedict R
17Beta-estradiol as a receptor-mediated cardioprotective agent.
The Journal of pharmacology and experimental therapeutics 2003;307(1):395-401.
2003: Hong Ting-Ting; Driscoll Edward M; White Andrew J; Sherigill Ardaman; Giboulot Thierry A; Lucchesi Benedict R
Glycoprotein IIb/IIIa receptor antagonist (2S)-2-[(2-Naphthyl-sulfonyl)amino]-3-[[2-([4-(4-piperidinyl)-2-[2-(4-piperidinyl)ethyl] butanoyl]amino)acetyl]amino]propanoic acid dihydrochloride (CRL42796), in combination with aspirin and/or enoxaparin, prevents coronary artery rethrombosis after successful thrombolytic treatment by recombinant tissue plasminogen activator.
The Journal of pharmacology and experimental therapeutics 2003;306(2):616-23.
2003: Hennan James K; Willens David E; Driscoll Edward M; Hong Ting-Ting; Giboulot Thierry; Lucchesi Benedict R
Prevention of carotid artery thrombosis after oral administration of the glycoprotein IIb/IIIa antagonist CRL42796.
Journal of cardiovascular pharmacology 2003;42(1):71-7.
2003: Fischbach Peter S; Barrett Terrance D; Reed Nathan J; Lucchesi Benedict R
SNC-80-induced preconditioning: selective activation of the mitochondrial adenosine triphosphate-gated potassium channel.
Journal of cardiovascular pharmacology 2003;41(5):744-50.
2002: Barrett Terrance D; Hennan James K; Marks Rory M; Lucchesi Benedict R
C-reactive-protein-associated increase in myocardial infarct size after ischemia/reperfusion.
The Journal of pharmacology and experimental therapeutics 2002;303(3):1007-13.
2002: Hennan James K; Hong Ting-Ting; Willens David E; Driscoll Edward M; Giboulot Thierry A; Lucchesi Benedict R
Prevention of experimental carotid and coronary artery thrombosis by the glycoprotein IIb/IIIa receptor antagonist CRL42796.
British journal of pharmacology 2002;136(6):927-37.
2002: Hennan James K; Hong Ting-Ting; Shergill Ardamanpal K; Driscoll Edward M; Cardin Alan D; Lucchesi Benedict R
Intimatan prevents arterial and venous thrombosis in a canine model of deep vessel wall injury.
The Journal of pharmacology and experimental therapeutics 2002;301(3):1151-6.
2002: Rodríguez Manuel; Lucchesi Benedict R; Schaper Jutta
Apoptosis in myocardial infarction.
Annals of medicine 2002;34(6):470-9.
2001: Hasa A A; Schmaier A H; Warnock M; Normolle D; Driscoll E; Lucchesi B R; Werns S W
Thrombostatin inhibits cyclic flow variations in stenosed canine coronary arteries.
Thrombosis and haemostasis 2001;86(5):1296-304.
2001: Fischbach P S; Barrett T D; Goyal R; Tran B C; Syed Z A; Hennan J K; Lucchesi B R
Conversion of atrial fibrillation by the experimental antiarrhythmic drug tedisamil in two canine models.
Journal of cardiovascular electrophysiology 2001;12(10):1138-44.
2001: Hennan J K; Huang J; Barrett T D; Driscoll E M; Willens D E; Park A M; Crofford L J; Lucchesi B R
Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries.
Circulation 2001;104(7):820-5.
2001: Lucchesi B R
2001 Torald Sollmann Award lecture. Looking toward the future, using lessons from the past.
The Journal of pharmacology and experimental therapeutics 2001;297(3):829-36.
2001: Barrett T D; Hennan J K; Fischbach P S; O'Neill B P; Driscoll Jr E M; Lucchesi B R
Tedisamil and dofetilide-induced torsades de pointes, rate and potassium dependence.
British journal of pharmacology 2001;132(7):1493-500.
2001: Patel M B; Kilgore K S; Ortolano G A; Gryboski C L; Qureshi M A; Marcovitz P; Naylor K B; Park J L; Wenz B; Gikakis N; Freedman R J; Lucchesi B R; O'Neill W W
Conditioned blood reperfusion during angioplasty (CoBRA) treatment of acute myocardial infarction.
Perfusion 2001;16 Suppl():39-49.
2001: Huang J; Feldbaum V M; Lucchesi B R; Werns S W
Effects of adenosine on thrombosis and thrombolysis in a canine experimental preparation.
Pharmacology 2001;63(3):166-74.
2000: Huang J; Driscoll E M; Gonzales M L; Park A M; Lucchesi B R
Prevention of arterial thrombosis by intravenously administered platelet P2T receptor antagonist AR-C69931MX in a canine model.
The Journal of pharmacology and experimental therapeutics 2000;295(2):492-9.
2000: Tanhehco E J; Lee H; Lucchesi B R
Sublytic complement attack reduces infarct size in rabbit isolated hearts: evidence for C5a-mediated cardioprotection.
Immunopharmacology 2000;49(3):391-9.
2000: Tanhehco E J; Yasojima K; McGeer P L; McGeer E G; Lucchesi B R
Preconditioning reduces myocardial complement gene expression in vivo.
American journal of physiology. Heart and circulatory physiology 2000;279(3):H1157-65.
2000: Tanhehco E J; Yasojima K; McGeer P L; Washington R A; Lucchesi B R
Free radicals upregulate complement expression in rabbit isolated heart.
American journal of physiology. Heart and circulatory physiology 2000;279(1):H195-201.
2000: Rebello S S; Blank H S; Lucchesi B R
Antithrombotic efficacy of single subcutaneous administration of a recombinant nematode anticoagulant peptide (rNAP5) in a canine model of coronary artery thrombolysis.
Thrombosis research 2000;98(6):531-40.
2000: Lucchesi B R; Tanhehco E J
Therapeutic potential of complement inhibitors in myocardial ischaemia.
Expert opinion on investigational drugs 2000;9(5):975-91.
2000: Kilgore K S; Lucchesi B R
Neutrophils and altered myocardial function.
American heart journal 2000;139(1 Pt 1):32-4.
2000: Tanhehco E J; Yasojima K; McGeer P L; Lucchesi B R
Acute cocaine exposure up-regulates complement expression in rabbit heart.
The Journal of pharmacology and experimental therapeutics 2000;292(1):201-8.
2000: Rebello S S; Huang J; Faul J D; Lucchesi B R
Role of extracellular ionized calcium in the in vitro assessment of GPIIb/IIIa receptor antagonists.
Journal of thrombosis and thrombolysis 2000;9(1):23-8.
1999: Tanhehco E J; Yasojima K; McGeer P L; Washington R A; Kilgore K S; Homeister J W; Lucchesi B R
Preconditioning reduces tissue complement gene expression in the rabbit isolated heart.
The American journal of physiology 1999;277(6 Pt 2):H2373-80.
1999: Annich G; White T; Damm D; Zhao Y; Mahdi F; Meinhardt J; Rebello S; Lucchesi B; Bartlett R H; Schmaier A H
Recombinant Kunitz protease inhibitory domain of the amyloid beta-protein precursor as an anticoagulant in venovenous extracorporeal circulation in rabbits.
Thrombosis and haemostasis 1999;82(5):1474-81.
1999: Park J L; Lucchesi B R
Mechanisms of myocardial reperfusion injury.
The Annals of thoracic surgery 1999;68(5):1905-12.
1999: Hasan A A; Rebello S S; Smith E; Srikanth S; Werns S; Driscoll E; Faul J; Brenner D; Normolle D; Lucchesi B R; Schmaier A H
Thrombostatin inhibits induced canine coronary thrombosis.
Thrombosis and haemostasis 1999;82(3):1182-7.
1999: Kilgore K S; Tanhehco E J; Naylor K B; Lucchesi B R
Ex vivo reversal of heparin-mediated cardioprotection by heparinase after ischemia and reperfusion.
The Journal of pharmacology and experimental therapeutics 1999;290(3):1041-7.
1999: Schwartz C F; Kilgore K S; Homeister J W; Levy B A; Lucchesi B R; Bolling S F
Increased rat cardiac allograft survival by the glycosaminoglycan pentosan polysulfate.
The Journal of surgical research 1999;86(1):24-8.
1999: Tanhehco E J; Kilgore K S; Liff D A; Murphy K L; Fung M S; Sun W N; Sun C; Lucchesi B R
The anti-factor D antibody, MAb 166-32, inhibits the alternative pathway of the human complement system.
Transplantation proceedings 1999;31(5):2168-71.
1999: Fischbach P S; Johnston P V; Friedrichs G S; Lucchesi B R
Tedisamil in a chronic canine model of atrial flutter.
Journal of cardiovascular pharmacology 1999;34(2):212-8.
1999: Tanhehco E J; Kilgore K S; Naylor K B; Park J L; Booth E A; Lucchesi B R
Reduction of myocardial infarct size after ischemia and reperfusion by the glycosaminoglycan pentosan polysulfate.
Journal of cardiovascular pharmacology 1999;34(1):153-61.
1999: Rebello S S; Huang J; Saito K; Saucedo J F; Bates E R; Lucchesi B R
Effect of time of 7E3 administration on rt-PA-induced reperfusion: study in a canine model of thrombus-based occlusion-reperfusion.
European journal of pharmacology 1999;374(3):399-410.
1999: Huang J; Rebello S S; Faul J D; Lucchesi B R
Correlation between the in vivo efficacy of GPIIb/IIIa receptor antagonists (m7E3, MK-383 and DMP-728) and ex vivo platelet inhibition.
Pharmacology 1999;58(5):252-64.
1999: Park J L; Kilgore K S; Naylor K B; Booth E A; Murphy K L; Lucchesi B R
N-Acetylheparin pretreatment reduces infarct size in the rabbit.
Pharmacology 1999;58(3):120-31.
1999: Huang J; Rebello S S; Rosenberg L A; Kaneko M; Sakurama T; Lucchesi B R
Temporary and partial inhibition of platelets by SM-20302 prevents coronary artery thrombosis in a chronic canine model.
European journal of pharmacology 1999;366(2-3):203-13.
1998: Rebello S S; Huang J; Shiu W J; Saito K; Kaneko M; Saitoh Y; Lucchesi B R
Pharmacokinetics and pharmacodynamics of SM-20302, a GPIIb/IIIa receptor antagonist, in anesthetized dogs.
Journal of cardiovascular pharmacology 1998;32(3):485-94.
1998: Black S C; Driscoll E M; Lucchesi B R
Effect of ramiprilat or captopril on myocardial infarct size: assessment in canine models of ischemia alone and ischemia with reperfusion.
Pharmacology 1998;57(1):35-46.
1998: Rebello S S; Huang J; Saito K; Lucchesi B R
In vivo efficacy of SM-20302, a GP IIb/IIIa receptor antagonist, correlates with ex vivo platelet inhibition in heparinized blood but not in citrated blood.
Arteriosclerosis, thrombosis, and vascular biology 1998;18(6):954-60.
1998: Yasojima K; Kilgore K S; Washington R A; Lucchesi B R; McGeer P L
Complement gene expression by rabbit heart: upregulation by ischemia and reperfusion.
Circulation research 1998;82(11):1224-30.
1998: Kilgore K S; Naylor K B; Tanhehco E J; Park J L; Booth E A; Washington R A; Lucchesi B R
The semisynthetic polysaccharide pentosan polysulfate prevents complement-mediated myocardial injury in the rabbit perfused heart.
The Journal of pharmacology and experimental therapeutics 1998;285(3):987-94.
1998: Kilgore K S; Park J L; Tanhehco E J; Booth E A; Marks R M; Lucchesi B R
Attenuation of interleukin-8 expression in C6-deficient rabbits after myocardial ischemia/reperfusion.
Journal of molecular and cellular cardiology 1998;30(1):75-85.
1998: Friedrichs G S; Abreu J N; Driscoll E M; Borlak J; Lucchesi B R
Antifibrillatory efficacy of long-term tedisamil administration in a postinfarcted canine model of ischemic ventricular fibrillation.
Journal of cardiovascular pharmacology 1998;31(1):56-66.
1998: Kilgore K S; Tanhehco E J; Park J L; Naylor K B; Anderson M B; Lucchesi B R
Reduction of myocardial infarct size in vivo by carbohydrate-based glycomimetics.
The Journal of pharmacology and experimental therapeutics 1998;284(1):427-35.
1997: Lucchesi B R; Kilgore K S
Complement inhibitors in myocardial ischemia/reperfusion injury.
Immunopharmacology 1997;38(1-2):27-42.
1997: Park J L; Tanhehco E J; Kilgore K S; Gralinski M R; Lucchesi B R
Reviparin-sodium prevents complement-mediated myocardial injury in the isolated rabbit heart.
Journal of cardiovascular pharmacology 1997;30(5):658-66.
1997: Rebello S S; Blank H S; Rote W E; Vlasuk G P; Lucchesi B R
Antithrombotic efficacy of a recombinant nematode anticoagulant peptide (rNAP5) in canine models of thrombosis after single subcutaneous administration.
The Journal of pharmacology and experimental therapeutics 1997;283(1):91-9.
1997: Rebello S S; Driscoll E M; Lucchesi B R
TP-9201, a glycoprotein IIb/IIIa platelet receptor antagonist, prevents rethrombosis after successful arterial thrombolysis in the dog.
Stroke; a journal of cerebral circulation 1997;28(9):1789-96.
1997: Gralinski M R; Park J L; Ozeck M A; Wiater B C; Lucchesi B R
LU 51198, a highly sulfated, low-molecular-weight heparin derivative, prevents complement-mediated myocardial injury in the perfused rabbit heart.
The Journal of pharmacology and experimental therapeutics 1997;282(2):554-60.
1997: Mousa S A; Mu D X; Lucchesi B R
Prevention of carotid artery thrombosis by oral platelet GPIIb/IIIa antagonist in dogs.
Stroke; a journal of cerebral circulation 1997;28(4):830-5; discussion 835-6.
1997: Rebello S S; Miller B V; Basler G C; Lucchesi B R
CVS-1123, a direct thrombin inhibitor, prevents occlusive arterial and venous thrombosis in a canine model of vascular injury.
Journal of cardiovascular pharmacology 1997;29(2):240-9.
1996: Cousins G R; Friedrichs G S; Sudo Y; Rebello S S; Rote W E; Vlasuk G P; Nolan T G; Mendoza C; Lucchesi B R
Orally effective CVS-1123 prevents coronary artery thrombosis in the conscious dog.
Circulation 1996;94(7):1705-12.
1996: Gralinski M R; Wiater B C; Assenmacher A N; Lucchesi B R
Selective inhibition of the alternative complement pathway by sCR1[desLHR-A] protects the rabbit isolated heart from human complement-mediated damage.
Immunopharmacology 1996;34(2-3):79-88.
1996: Gralinski M R; Black S C; Stancato L F; Kilgore K S; Campau P A; Park J L; Ozeck M J; Pratt W B; Lucchesi B R
Heat stress protects the perfused rabbit heart from complement-mediated injury.
The American journal of physiology 1996;271(2 Pt 2):H571-8.
1996: Friedrichs G S; Abreu J N; Black S C; Chi L; Lucchesi B R
5-hydroxydecanoate fails to attenuate ventricular fibrillation in a conscious canine model of sudden cardiac death.
European journal of pharmacology 1996;306(1-3):99-106.
1996: Sudo Y; Lucchesi B R
Antithrombotic effect of GYKI-14766 in a canine model of arterial and venous rethrombosis: a comparison with heparin.
Journal of cardiovascular pharmacology 1996;27(4):545-55.
1996: Chi L; Park J L; Friedrichs G S; Banglawala Y A; Perez M A; Tanhehco E J; Lucchesi B R
Effects of tedisamil (KC-8857) on cardiac electrophysiology and ventricular fibrillation in the rabbit isolated heart.
British journal of pharmacology 1996;117(6):1261-9.
1996: Mousa S A; DeGrado W F; Mu D X; Kapil R P; Lucchesi B R; Reilly T M
Oral antiplatelet, antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa antagonist.
Circulation 1996;93(3):537-43.
1995: Sudo Y; Kilgore K S; Lucchesi B R
Monoclonal antibody [7E3 F(ab')2] prevents arterial but not venous rethrombosis.
Journal of cardiovascular pharmacology 1995;26(2):241-50.
1995: Virkhaus R; Lucchesi B R; Simpson P J; Shebuski R J
The role of adhesion molecules in cardiovascular pharmacology: meeting review.
The Journal of pharmacology and experimental therapeutics 1995;273(2):569-75.
1995: Black S C; Gralinski M R; Friedrichs G S; Kilgore K S; Driscoll E M; Lucchesi B R
Cardioprotective effects of heparin or N-acetylheparin in an in vivo model of myocardial ischaemic and reperfusion injury.
Cardiovascular research 1995;29(5):629-36.
1995: Friedrichs G S; Chi L; Gralinski M R; Black S C; Basler G C; Mu D X; Pewitt S R; Johnson C R; Lucchesi B R
MS-551 protects against ventricular fibrillation in a chronic canine model of sudden cardiac death.
Journal of cardiovascular pharmacology 1995;25(2):314-23.
1995: Minami M; Driscoll E M; Simpson P J; Hoff P T; Lucchesi B R
Effects of BMY21190, an inhibitor of cAMP phosphodiesterase, on infarct size and myeloperoxidase activity in the ischemic myocardium of a canine occlusion-reperfusion model.
Pharmacology 1995;50(1):24-33.
1994: Black S C; Gralinski M R; McCormack J G; Driscoll E M; Lucchesi B R
Effect of ranolazine on infarct size in a canine model of regional myocardial ischemia/reperfusion.
Journal of cardiovascular pharmacology 1994;24(6):921-8.
1994: Markland F S; Friedrichs G S; Pewitt S R; Lucchesi B R
Thrombolytic effects of recombinant fibrolase or APSAC in a canine model of carotid artery thrombosis.
Circulation 1994;90(5):2448-56.
1994: Chi L; Friedrichs G S; Oh J Y; Green A L; Lucchesi B R
Effect of Ado A1- and A2-receptor activation on ventricular fibrillation during hypoxia-reoxygenation.
The American journal of physiology 1994;267(4 Pt 2):H1447-54.
1994: Friedrichs G S; Kilgore K S; Manley P J; Gralinski M R; Lucchesi B R
Effects of heparin and N-acetyl heparin on ischemia/reperfusion-induced alterations in myocardial function in the rabbit isolated heart.
Circulation research 1994;75(4):701-10.
1994: Black S C; Schasteen C S; Weiss R H; Riley D P; Driscoll E M; Lucchesi B R
Inhibition of in vivo myocardial ischemic and reperfusion injury by a synthetic manganese-based superoxide dismutase mimetic.
The Journal of pharmacology and experimental therapeutics 1994;270(3):1208-15.
1994: Friedrichs G S; Chi L; Green A L; Lucchesi B R
Antifibrillatory effects of clofilium in the rabbit isolated heart.
British journal of pharmacology 1994;113(1):209-15.
1994: Gralinski M R; Black S C; Kilgore K S; Chou A Y; McCormack J G; Lucchesi B R
Cardioprotective effects of ranolazine (RS-43285) in the isolated perfused rabbit heart.
Cardiovascular research 1994;28(8):1231-7.
1994: Kilgore K S; Friedrichs G S; Johnson C R; Schasteen C S; Riley D P; Weiss R H; Ryan U; Lucchesi B R
Protective effects of the SOD-mimetic SC-52608 against ischemia/reperfusion damage in the rabbit isolated heart.
Journal of molecular and cellular cardiology 1994;26(8):995-1006.
1994: Rote W E; Nedelman M A; Mu D X; Manley P J; Weisman H; Cunningham M R; Lucchesi B R
Chimeric 7E3 prevents carotid artery thrombosis in cynomolgus monkeys.
Stroke; a journal of cerebral circulation 1994;25(6):1223-32; discussion 1233.
1994: Black S C; Lucchesi B R
Potassium channel openers are likely to be proarrhythmic in the diseased human heart.
Cardiovascular research 1994;28(6):923-4; discussion 926-9.
1994: Kilgore K S; Friedrichs G S; Homeister J W; Lucchesi B R
The complement system in myocardial ischaemia/reperfusion injury.
Cardiovascular research 1994;28(4):437-44.
1994: Werns S W; Rote W E; Davis J H; Guevara T; Lucchesi B R
Nitroglycerin inhibits experimental thrombosis and reocclusion after thrombolysis.
American heart journal 1994;127(4 Pt 1):727-37.
1994: Eitzman D T; Chi L; Saggin L; Schwartz R S; Lucchesi B R; Fay W P
Heparin neutralization by platelet-rich thrombi. Role of platelet factor 4.
Circulation 1994;89(4):1523-9.
1994: Rote W E; Davis J H; Mousa S A; Reilly T M; Lucchesi B R
Antithrombotic effects of DMP 728, a platelet GPIIb/IIIa receptor antagonist, in a canine model of arterial thrombosis.
Journal of cardiovascular pharmacology 1994;23(4):681-9.
1994: Lucchesi B R
Complement, neutrophils and free radicals: mediators of reperfusion injury.
Arzneimittel-Forschung 1994;44(3A):420-32.
1994: Rote W E; Mu D X; Bates E R; Nedelman M A; Lucchesi B R
Prevention of rethrombosis after coronary thrombolysis in a chronic canine model. II. Adjunctive therapy with r-hirudin.
Journal of cardiovascular pharmacology 1994;23(2):203-11.
1994: Rote W E; Mu D X; Bates E R; Nedelman M A; Lucchesi B R
Prevention of rethrombosis after coronary thrombolysis in a chronic canine model. I. Adjunctive therapy with monoclonal antibody 7E3 F(ab')2 fragment.
Journal of cardiovascular pharmacology 1994;23(2):194-202.
1994: Kilgore K S; Homeister J W; Satoh P S; Lucchesi B R
Sulfhydryl compounds, captopril, and MPG inhibit complement-mediated myocardial injury.
The American journal of physiology 1994;266(1 Pt 2):H28-35.
1994: Trikha M; Rote W E; Manley P J; Lucchesi B R; Markland F S
Purification and characterization of platelet aggregation inhibitors from snake venoms.
Thrombosis research 1994;73(1):39-52.
1994: Chi L; Black S C; Friedrichs G S; Lucchesi B R
ATP sensitive potassium channels and ischemic heart disease.
Cardiovascular research 1994;28(1):136-7.
1994: Friedrichs G S; Chi L; Black S C; Manley P J; Lucchesi B R
Antiarrhythmic agent, MS-551, protects against pinacidil + hypoxia-induced ventricular fibrillation in Langendorff-perfused rabbit isolated heart.
Journal of cardiovascular pharmacology 1994;23(1):120-6.
1994: Homeister J W; Lucchesi B R
Complement activation and inhibition in myocardial ischemia and reperfusion injury.
Annual review of pharmacology and toxicology 1994;34():17-40.
1993: Lucchesi B R
Complement activation, neutrophils, and oxygen radicals in reperfusion injury.
Stroke; a journal of cerebral circulation 1993;24(12 Suppl):I41-7; discussion I38-40.
1993: Black S C; Fagbemi S O; Chi L; Friedrichs G S; Lucchesi B R
Phorbol ester-induced ventricular fibrillation in the Langendorff-perfused rabbit heart: antagonism by staurosporine and glibenclamide.
Journal of molecular and cellular cardiology 1993;25(12):1427-38.
1993: Black S C; Butterfield J L; Lucchesi B R
Protection against programmed electrical stimulation-induced ventricular tachycardia and sudden cardiac death by NE-10064, a class III antiarrhythmic drug.
Journal of cardiovascular pharmacology 1993;22(6):810-8.
1993: Black S C; Friedrichs G S; Lucchesi B R
The autonomic nervous system, myocardial infarct size and ventricular fibrillation.
Journal of molecular and cellular cardiology 1993;25(11):1291-2.
1993: Uprichard A C; Chi L; Lucchesi B R
Functional consequence of big endothelin conversion: demonstration with isolated neutrophils but not in a postinfarction model.
Pharmacology 1993;47(5):277-85.
1993: Rote W E; Mu D X; Roncinske R A; Frelinger A L; Lucchesi B R
Prevention of experimental carotid artery thrombosis by applaggin.
The Journal of pharmacology and experimental therapeutics 1993;267(2):809-14.
1993: Lucchesi B R; Chi L; Friedrichs G S; Black S C; Uprichard A C
Antiarrhythmic versus antifibrillatory actions: inference from experimental studies.
The American journal of cardiology 1993;72(16):25F-44F.
1993: Kilgore K S; Lucchesi B R
Reperfusion injury after myocardial infarction: the role of free radicals and the inflammatory response.
Clinical biochemistry 1993;26(5):359-70.
1993: Minami M; Driscoll E M; Lucchesi B R
Antithrombotic effects of BMY21190, an inhibitor of cAMP phosphodiesterase, in a canine model of coronary artery thrombosis.
Japanese circulation journal 1993;57(10):979-92.
1993: Friedrichs G S; Chi L; Black S C; Manley P J; Oh J Y; Lucchesi B R
Antifibrillatory effects of ibutilide in the rabbit isolated heart: mediation via ATP-dependent potassium channels.
The Journal of pharmacology and experimental therapeutics 1993;266(3):1348-54.
1993: Tschopp J F; Driscoll E M; Mu D X; Black S C; Pierschbacher M D; Lucchesi B R
Inhibition of coronary artery reocclusion after thrombolysis with an RGD-containing peptide with no significant effect on bleeding time.
Coronary artery disease 1993;4(9):809-17.
1993: Kilgore K S; Lucchesi B R
Effect of hypoxia and reoxygenation on the isolated rabbit heart determined by monoclonal antimyosin antibody uptake.
Cardiovascular research 1993;27(7):1260-7.
1993: Rote W E; Mu D X; Lucchesi B R
Thromboxane antagonism in experimental canine carotid artery thrombosis.
Stroke; a journal of cerebral circulation 1993;24(6):820-7; discussion 827-8.
1993: Fagbemi S O; Chi L; Lucchesi B R
Antifibrillatory and profibrillatory actions of selected class I antiarrhythmic agents.
Journal of cardiovascular pharmacology 1993;21(5):709-19.
1993: Rote W E; Werns S W; Davis J H; Feigen L P; Kilgore K S; Lucchesi B R
Platelet GPIIb/IIIa receptor inhibition by SC-49992 prevents thrombosis and rethrombosis in the canine carotid artery.
Cardiovascular research 1993;27(3):500-7.
1993: Black S C; Lucchesi B R
Heat shock proteins and the ischemic heart. An endogenous protective mechanism.
Circulation 1993;87(3):1048-51.
1993: Mickelson J K; Hoff P T; Homeister J W; Fantone J C; Lucchesi B R
High dose intravenous aspirin, not low dose intravenous or oral aspirin, inhibits thrombus formation and stabilizes blood flow in experimental coronary vascular injury.
Journal of the American College of Cardiology 1993;21(2):502-10.
1993: Homeister J W; Satoh P S; Kilgore K S; Lucchesi B R
Soluble complement receptor type 1 prevents human complement-mediated damage of the rabbit isolated heart.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(3):1055-64.
1993: Chi L; Black S C; Kuo P I; Fagbemi S O; Lucchesi B R
Actions of pinacidil at a reduced potassium concentration: a direct cardiac effect possibly involving the ATP-dependent potassium channel.
Journal of cardiovascular pharmacology 1993;21(2):179-90.
1992: Black S C; Driscoll E M; Lucchesi B R
Inhibition of platelet-activating factor fails to limit ischemia and reperfusion-induced myocardial damage.
Journal of cardiovascular pharmacology 1992;20(6):997-1005.
1992: Werns S W; Fantone J C; Ventura A; Lucchesi B R
Myocardial glutathione depletion impairs recovery of isolated blood-perfused hearts after global ischaemia.
Journal of molecular and cellular cardiology 1992;24(11):1215-20.
1992: Homeister J W; Satoh P; Lucchesi B R
Effects of complement activation in the isolated heart. Role of the terminal complement components.
Circulation research 1992;71(2):303-19.
1991: Schumacher W A; Fantone J C; Kunkel S E; Webb R C; Lucchesi B R
The anaphylatoxins C3a and C5a are vasodilators in the canine coronary vasculature in vitro and in vivo.
Agents and actions 1991;34(3-4):345-9.
1991: Venkatesh N; Lynch J J; Uprichard A C; Kitzen J M; Singh B N; Lucchesi B R
Hypothyroidism renders protection against lethal ventricular arrhythmias in a conscious canine model of sudden death.
Journal of cardiovascular pharmacology 1991;18(5):703-10.
1991: Black S C; Chi L G; Mu D X; Lucchesi B R
The antifibrillatory actions of UK-68,798, a class III antiarrhythmic agent.
The Journal of pharmacology and experimental therapeutics 1991;258(2):416-23.
1991: Werns S W; Grum C M; Ventura A; Hahn R A; Ho P P; Towner R D; Fantone J C; Schork M A; Lucchesi B R
Xanthine oxidase inhibition does not limit canine infarct size.
Circulation 1991;83(3):995-1005.
1991: Chi L G; Mu D X; Lucchesi B R
Electrophysiology and antiarrhythmic actions of E-4031 in the experimental animal model of sudden coronary death.
Journal of cardiovascular pharmacology 1991;17(2):285-95.
1991: Lucchesi B R; Hoff P T; Tamura Y
Cardioprotective effects of amlodipine in animal models of ischemia and reperfusion.
Journal of cardiovascular pharmacology 1991;17 Suppl 1():S34-9.
1990: Hoff P T; Tamura Y; Lucchesi B R
Cardioprotective effects of amlodipine on ischemia and reperfusion in two experimental models.
The American journal of cardiology 1990;66(18):10H-16H.
1990: Li G C; Vasquez J A; Gallagher K P; Lucchesi B R
Myocardial protection with preconditioning.
Circulation 1990;82(2):609-19.
1990: Homeister J W; Hoff P T; Fletcher D D; Lucchesi B R
Combined adenosine and lidocaine administration limits myocardial reperfusion injury.
Circulation 1990;82(2):595-608.
1990: Chi L G; Mu D X; Driscoll E M; Lucchesi B R
Antiarrhythmic and electrophysiologic actions of CK-3579 and sematilide in a conscious canine model of sudden coronary death.
Journal of cardiovascular pharmacology 1990;16(2):312-24.
1990: Kitzen J M; Chi L G; Uprichard A C; Lucchesi B R
Effects of combined thromboxane synthetase inhibition/thromboxane receptor antagonism in two models of sudden cardiac death in the canine: limited role for thromboxane.
Journal of cardiovascular pharmacology 1990;16(1):68-80.
1990: Lucchesi B R
Myocardial ischemia, reperfusion and free radical injury.
The American journal of cardiology 1990;65(19):14I-23I.
1990: Werns S W; Lucchesi B R
Free radicals and ischemic tissue injury.
Trends in pharmacological sciences 1990;11(4):161-6.
1990: Chi L; Uprichard A C; Lucchesi B R
Profibrillatory actions of pinacidil in a conscious canine model of sudden coronary death.
Journal of cardiovascular pharmacology 1990;15(3):452-64.
1990: Mickelson J K; Simpson P J; Cronin M; Homeister J W; Laywell E; Kitzen J; Lucchesi B R
Antiplatelet antibody [7E3 F(ab')2] prevents rethrombosis after recombinant tissue-type plasminogen activator-induced coronary artery thrombolysis in a canine model.
Circulation 1990;81(2):617-27.
1990: Simpson P J; Todd R F; Mickelson J K; Fantone J C; Gallagher K P; Lee K A; Tamura Y; Cronin M; Lucchesi B R
Sustained limitation of myocardial reperfusion injury by a monoclonal antibody that alters leukocyte function.
Circulation 1990;81(1):226-37.
1990: Schumacher W A; Lucchesi B R
Effect of diltiazem on experimental coronary artery thrombosis in dogs.
Pharmacology 1990;41(1):16-23.
1990: Lucchesi B R
Modulation of leukocyte-mediated myocardial reperfusion injury.
Annual review of physiology 1990;52():561-76.
1990: Sisson J C; Johnson J; Bolgos G; Lynch J J; Uprichard A; Driscoll E; Wieland D M; Lucchesi B
Portrayal of adrenergic denervation in the presence of myocardial infarction: a feasibility study.
American journal of physiologic imaging 1990;5(4):151-66.
1989: Lucchesi B R; Werns S W; Fantone J C
The role of the neutrophil and free radicals in ischemic myocardial injury.
Journal of molecular and cellular cardiology 1989;21(12):1241-51.
1989: Lucchesi B R
Role of calcium on excitation-contraction coupling in cardiac and vascular smooth muscle.
Circulation 1989;80(6 Suppl):IV1-13.
1989: Uprichard A C; Chi L G; Kitzen J M; Lynch J J; Frye J W; Lucchesi B R
Celiprolol does not protect against ventricular tachycardia or sudden death in the conscious canine: a comparison with pindolol in assessing the role of intrinsic sympathomimetic activity.
The Journal of pharmacology and experimental therapeutics 1989;251(2):571-7.
1989: Hoff P T; Tamura Y; Lucchesi B R
Cardioprotective effects of amlodipine in the ischemic-reperfused heart.
The American journal of cardiology 1989;64(17):101I-115I discussion 115I-116I.
1989: Lucchesi B R; Tamura Y
Cardioprotective effects of amlodipine in the ischemic-reperfused heart.
American heart journal 1989;118(5 Pt 2):1121-2.
1989: Lynch J J; Uprichard A C; Frye J W; Driscoll E M; Kitzen J M; Lucchesi B R
Effects of the positive inotropic agents milrinone and pimobendan on the development of lethal ischemic arrhythmias in conscious dogs with recent myocardial infarction.
Journal of cardiovascular pharmacology 1989;14(4):585-97.
1989: Uprichard A C; Chi L G; Lynch J J; Driscoll E M; Frye J W; Lucchesi B R
Alinidine reduces the incidence of ischemic ventricular fibrillation in a conscious canine model, a protective effect antagonized by overdrive atrial pacing.
Journal of cardiovascular pharmacology 1989;14(3):475-82.
1989: Mickelson J K; Simpson P J; Lucchesi B R
Streptokinase improves reperfusion blood flow after coronary artery occlusion.
International journal of cardiology 1989;23(3):373-84.
1989: Mickelson J K; Simpson P J; Lucchesi B R
Antiplatelet monoclonal F(ab')2 antibody directed against the platelet GPIIb/IIIa receptor complex prevents coronary artery thrombosis in the canine heart.
Journal of molecular and cellular cardiology 1989;21(4):393-405.
1989: Chi L G; Tamura Y; Hoff P T; Macha M; Gallagher K P; Schork M A; Lucchesi B R
Effect of superoxide dismutase on myocardial infarct size in the canine heart after 6 hours of regional ischemia and reperfusion: a demonstration of myocardial salvage.
Circulation research 1989;64(4):665-75.
1989: Nelson S D; Lynch J J; Sanders D; Montgomery D G; Lucchesi B R
Electrophysiologic actions and antifibrillatory efficacy of subacute left stellectomy in a conscious, post-infarction canine model of ischemic ventricular fibrillation.
International journal of cardiology 1989;22(3):365-76.
1989: Werns S W; Lucchesi B R
Myocardial ischemia and reperfusion: the role of oxygen radicals in tissue injury.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1989;2(6):761-9.
1988: Mitsos S E; Kim D; Lucchesi B R; Fantone J C
Modulation of myoglobin-H2O2-mediated peroxidation reactions by sulfhydryl compounds.
Laboratory investigation; a journal of technical methods and pathology 1988;59(6):824-30.
1988: Söhngen W; Winbury M M; Kitzen J M; Ventura A; Lucchesi B R
The mechanism for the clonidine-induced coronary artery dilatation in the canine heart.
Journal of cardiovascular pharmacology 1988;12(6):689-700.
1988: Simpson P J; Fantone J C; Mickelson J K; Gallagher K P; Lucchesi B R
Identification of a time window for therapy to reduce experimental canine myocardial injury: suppression of neutrophil activation during 72 hours of reperfusion.
Circulation research 1988;63(6):1070-9.
1988: Patterson E; Lucchesi B R
Electrophysiologic and antiarrhythmic actions of nadolol: acute ischemia in the presence of previous myocardial infarction.
American heart journal 1988;116(5 Pt 1):1223-32.
1988: Tamura Y; Chi L G; Driscoll E M; Hoff P T; Freeman B A; Gallagher K P; Lucchesi B R
Superoxide dismutase conjugated to polyethylene glycol provides sustained protection against myocardial ischemia/reperfusion injury in canine heart.
Circulation research 1988;63(5):944-59.
1988: Nelson S D; Lucchesi B R; Sanders D G; Lynch J J
Antiarrhythmic actions of left stellectomy in digitalis-mediated malignant ventricular arrhythmias in the postinfarcted canine heart.
Journal of cardiovascular pharmacology 1988;12(2):196-207.
1988: Mickelson J K; Simpson P J; Jackson C V; Lucchesi B R
Protection of myocardial function and coronary vasculature by streptokinase.
Journal of cardiovascular pharmacology 1988;12(2):186-95.
1988: Sisson J C; Lynch J J; Johnson J; Jaques S; Wu D; Bolgos G; Lucchesi B R; Wieland D M
Scintigraphic detection of regional disruption of adrenergic neurons in the heart.
American heart journal 1988;116(1 Pt 1):67-76.
1988: Söhngen W; Mickelson J K; Simpson P J; Lucchesi B R
Recombinant single-chain urokinase-type plasminogen activator (rscu-PA) induces thrombolysis and systemic fibrinolysis in a canine model of coronary artery thrombosis.
Thrombosis research 1988;51(1):63-74.
1988: Larson L O; Hantler C B; Lynch J J; Landau S N; Buben J A; Lucchesi B R; Knight P R
Cardiac electrophysiologic interactions of bepridil, a new calcium antagonist, with enflurane, halothane, and isoflurane.
Journal of cardiothoracic anesthesia 1988;2(3):346-55.
1988: Lynch J J; Simpson P J; Gallagher K P; McClanahan T B; Lee K A; Lucchesi B R
Increase in experimental infarct size with digoxin in a canine model of myocardial ischemia-reperfusion injury.
American heart journal 1988;115(6):1171-82.
1988: Mickelson J K; Simpson P J; Lucchesi B R
Myocardial dysfunction and coronary vasoconstriction induced by platelet-activating factor in the post-infarcted rabbit isolated heart.
Journal of molecular and cellular cardiology 1988;20(6):547-61.
1988: Kitzen J M; Lynch J J; Driscoll E M; Lucchesi B R
Cardiac electrophysiologic and hemodynamic activity of pimobendan (UD-CG 115 BS), a new inotropic agent.
The Journal of pharmacology and experimental therapeutics 1988;244(3):929-39.
1988: Simpson P J; Todd R F; Fantone J C; Mickelson J K; Griffin J D; Lucchesi B R
Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mo1, anti-CD11b) that inhibits leukocyte adhesion.
The Journal of clinical investigation 1988;81(2):624-9.
1988: Simpson P J; Mickelson J; Fantone J C; Gallagher K P; Lucchesi B R
Reduction of experimental canine myocardial infarct size with prostaglandin E1: inhibition of neutrophil migration and activation.
The Journal of pharmacology and experimental therapeutics 1988;244(2):619-24.
1988: Lynch J J; Lucchesi B R
Effect of digoxin on the extent of injury and the severity of arrhythmias during acute myocardial ischemia and infarction in the dog.
Journal of cardiovascular pharmacology 1988;11(2):193-203.
1988: Lynch J J; Kitzen J M; Hoff P T; Lucchesi B R
Reduction in digitalis-associated postinfarction mortality with nadolol in conscious dogs.
American heart journal 1988;115(1 Pt 1):67-76.
1988: Werns S W; Simpson P J; Mickelson J K; Shea M J; Pitt B; Lucchesi B R
Sustained limitation by superoxide dismutase of canine myocardial injury due to regional ischemia followed by reperfusion.
Journal of cardiovascular pharmacology 1988;11(1):36-44.
1988: Patterson E; Gibson J K; Lucchesi B R
Antiarrhythmic and arrhythmogenic actions of methyl lidocaine during the recovery phase after canine myocardial infarction.
Pharmacology 1988;36(2):73-83.
1988: Werns S W; Lucchesi B R
Leukocytes, oxygen radicals, and myocardial injury due to ischemia and reperfusion.
Free radical biology & medicine 1988;4(1):31-7.
1988: Kitzen J M; Lynch J J; Uprichard A C; Venkatesh N; Lucchesi B R
Failure of thromboxane synthetase inhibition to protect the postinfarcted heart against the induction of ventricular tachycardia and ventricular fibrillation in a conscious canine model of sudden coronary death.
Pharmacology 1988;37(3):171-86.
1988: Werns S W; Eller B T; Shea M J; Simpson P J; Dysko R C; Abrams G D; Lucchesi B R
Protection of reperfused ischemic canine myocardium by CI-922, a new inhibitor of leukocyte activation.
Journal of cardiovascular pharmacology 1988;12(5):608-14.
1988: Lynch J J; Kitzen J M; Hoff P T; Lucchesi B R
Effects of pimobendan (UD-CG 115 BS), a new positive inotropic agent, on ventricular tachycardia and ischemic ventricular fibrillation in a conscious canine model of recent myocardial infarction.
Journal of cardiovascular pharmacology 1988;12(5):547-54.
1987: Jackson C V; Pope T K; Lucchesi B R
Coronary artery vasodilation in the canine: physiological and pharmacological roles of beta-adrenergic receptors.
Journal of cardiovascular pharmacology 1987;10(2):196-204.
1987: Simpson P J; Lucchesi B R
Free radicals and myocardial ischemia and reperfusion injury.
The Journal of laboratory and clinical medicine 1987;110(1):13-30.
1987: Wilber D J; Lynch J J; Montgomery D G; Lucchesi B R
Alpha-adrenergic influences in canine ischemic sudden death: effects of alpha 1-adrenoceptor blockade with prazosin.
Journal of cardiovascular pharmacology 1987;10(1):96-106.
1987: Mickelson J K; Simpson P J; Gallas M T; Lucchesi B R
Thromboxane synthetase inhibition with CGS 13080 improves coronary blood flow after streptokinase-induced thrombolysis.
American heart journal 1987;113(6):1345-52.
1987: Giger U; Boxer L A; Simpson P J; Lucchesi B R; Todd R F
Deficiency of leukocyte surface glycoproteins Mo1, LFA-1, and Leu M5 in a dog with recurrent bacterial infections: an animal model.
Blood 1987;69(6):1622-30.
1987: Lynch J J; Nelson S D; MacEwen S A; Driscoll E M; Lucchesi B R
Antifibrillatory efficacy of concomitant beta adrenergic receptor blockade with dilevalol, the R,R-isomer of labetalol, and muscarinic receptor blockade with methylscopolamine.
The Journal of pharmacology and experimental therapeutics 1987;241(2):741-9.
1987: Simpson P J; Mickelson J; Fantone J C; Gallagher K P; Lucchesi B R
Iloprost inhibits neutrophil function in vitro and in vivo and limits experimental infarct size in canine heart.
Circulation research 1987;60(5):666-73.
1987: Simpson P J; Mickelson J K; Lucchesi B R
Free radical scavengers in myocardial ischemia.
Federation proceedings 1987;46(7):2413-21.
1987: Werns S W; Shea M J; Vaporciyan A; Phan S; Abrams G D; Buda A J; Pitt B; Lucchesi B R
Superoxide dismutase does not cause scar thinning after myocardial infarction.
Journal of the American College of Cardiology 1987;9(4):898-902.
1987: Werns S W; Lucchesi B R
Inflammation and myocardial infarction.
British medical bulletin 1987;43(2):460-71.
1987: Lynch J J; Montgomery D G; Nelson S D; Huante D M; Lucchesi B R
Lack of concordance between the antiarrhythmic and antifibrillatory actions of UM-424, a quaternary ammonium analogue of propranolol.
Journal of cardiovascular pharmacology 1987;9(4):414-24.
1987: Kou W H; Nelson S D; Lynch J J; Montgomery D G; DiCarlo L; Lucchesi B R
Effect of flecainide acetate on prevention of electrical induction of ventricular tachycardia and occurrence of ischemic ventricular fibrillation during the early postmyocardial infarction period: evaluation in a conscious canine model of sudden death.
Journal of the American College of Cardiology 1987;9(2):359-65.
1987: Lucchesi B R; Mickelson J K; Homeister J W; Jackson C V
Interaction of the formed elements of blood with the coronary vasculature in vivo.
Federation proceedings 1987;46(1):63-72.
1987: Simpson P J; Mitsos S E; Ventura A; Gallagher K P; Fantone J C; Abrams G D; Schork M A; Lucchesi B R
Prostacyclin protects ischemic reperfused myocardium in the dog by inhibition of neutrophil activation.
American heart journal 1987;113(1):129-37.
1987: Kopia G A; Lucchesi B R
Antifibrillatory action of bretylium: role of the sympathetic nervous system.
Pharmacology 1987;34(1):37-47.
1987: Jolly S R; Kipnis J N; Lucchesi B R
Cardiovascular depression by verapamil: reversal by glucagon and interactions with propranolol.
Pharmacology 1987;35(5):249-55.
1987: Lynch J J; DiCarlo L A; Montgomery D G; Lucchesi B R
Effects of flecainide acetate on ventricular tachyarrhythmia and fibrillation in dogs with recent myocardial infarction.
Pharmacology 1987;35(4):181-93.
1987: Eller B T; Lynch J J; Patterson E; Lucchesi B R
Electrophysiologic and antiarrhythmic actions of sulphinpyrazone and its sulfide metabolite G25671.
Pharmacology 1987;34(2-3):121-30.
1987: Patterson E; Shlafer M; Walden K M; Khazaeli M B; Montgomery D G; Lucchesi B R
Changes in cardiac muscle function and biochemistry produced by long-term amiodarone and amiodarone + triiodothyronine administration in the rabbit.
Pharmacology 1987;35(3):130-40.
1986: Lynch J J; Montgomery D G; Lucchesi B R
Cardiac electrophysiologic actions of SCH 19927 (Dilevalol), the R,R-isomer of labetalol.
The Journal of pharmacology and experimental therapeutics 1986;239(3):719-23.
1986: Jackson C V; Mickelson J K; Pope T K; Rao P S; Lucchesi B R
O2 free radical-mediated myocardial and vascular dysfunction.
The American journal of physiology 1986;251(6 Pt 2):H1225-31.
1986: Lynch J J; Montgomery D G; Lucchesi B R
The effects of calcium entry blockade on the vulnerability of infarcted canine myocardium toward ventricular fibrillation.
The Journal of pharmacology and experimental therapeutics 1986;239(2):340-5.
1986: Lynch J J; DiCarlo L A; Montgomery D G; Hassan T; Lucchesi B R
Electrophysiologic actions of pirmenol in dogs with recent myocardial infarction.
American heart journal 1986;112(4):752-8.
1986: Jolly S R; Kane W J; Hook B G; Abrams G D; Kunkel S L; Lucchesi B R
Reduction of myocardial infarct size by neutrophil depletion: effect of duration of occlusion.
American heart journal 1986;112(4):682-90.
1986: Patterson E; Walden K M; Khazaeli M B; Montgomery D G; Lucchesi B R
Cardiac electrophysiologic effects of acute and chronic amiodarone administration in the isolated perfused rabbit heart: altered thyroid hormone metabolism.
The Journal of pharmacology and experimental therapeutics 1986;239(1):179-84.
1986: Mitsos S E; Fantone J C; Gallagher K P; Walden K M; Simpson P J; Abrams G D; Schork M A; Lucchesi B R
Canine myocardial reperfusion injury: protection by a free radical scavenger, N-2-mercaptopropionyl glycine.
Journal of cardiovascular pharmacology 1986;8(5):978-88.
1986: Lynch J J; DiCarlo L A; Montgomery D G; Lucchesi B R
Electrophysiologic effects of bepridil in normal and infarcted canine myocardium.
Journal of cardiovascular pharmacology 1986;8(5):957-66.
1986: Simpson P J; Smith C B; Rosenthal G; Lucchesi B R
Reduction in the incidence of thrombosis by the thromboxane synthetase inhibitor CGS 13080 in a canine model of coronary artery injury.
The Journal of pharmacology and experimental therapeutics 1986;238(2):497-501.
1986: Wilber D J; Lynch J J; Lucchesi B R
Electrophysiologic effects of prazosin during acute myocardial ischemia.
European journal of pharmacology 1986;127(1-2):157-61.
1986: Jackson C V; Mickelson J K; Stringer K; Rao P S; Lucchesi B R
Electrolysis-induced myocardial dysfunction. A novel method for the study of free radical mediated tissue injury.
Journal of pharmacological methods 1986;15(4):305-20.
1986: Lucchesi B R; Lynch J J
Preclinical assessment of antiarrhythmic drugs.
Federation proceedings 1986;45(8):2197-205.
1986: Werns S W; Shea M J; Lucchesi B R
Free radicals and myocardial injury: pharmacologic implications.
Circulation 1986;74(1):1-5.
1986: Lynch J J; Montgomery D G; Lucchesi B R
Facilitation of lethal ventricular arrhythmias by therapeutic digoxin in conscious post infarction dogs.
American heart journal 1986;111(5):883-90.
1986: Mitsos S E; Askew T E; Fantone J C; Kunkel S L; Abrams G D; Schork A; Lucchesi B R
Protective effects of N-2-mercaptopropionyl glycine against myocardial reperfusion injury after neutrophil depletion in the dog: evidence for the role of intracellular-derived free radicals.
Circulation 1986;73(5):1077-86.
1986: Gibson J K; Patterson E; Lucchesi B R
Electrophysiologic, antiarrhythmic and cardiovascular actions of UM301, a quaternary ammonium compound.
The Journal of pharmacology and experimental therapeutics 1986;237(1):318-25.
1986: Lynch J; Montgomery D; Ventura A; Wilber D; Lucchesi B R
Antiarrhythmic vs. antifibrillatory activity of the basic diphenylhydantoin derivative 3-[3-(4-phenyl-1-piperidyl)propyl]-5-(4-methoxyphenyl)-5-phenylhydantoin hydrochloride.
Arzneimittel-Forschung 1986;36(3):475-81.
1986: Werns S W; Shea M J; Mitsos S E; Dysko R C; Fantone J C; Schork M A; Abrams G D; Pitt B; Lucchesi B R
Reduction of the size of infarction by allopurinol in the ischemic-reperfused canine heart.
Circulation 1986;73(3):518-24.
1986: Jackson C V; Schumacher W A; Kunkel S L; Driscoll E M; Lucchesi B R
Platelet-activating factor and the release of a platelet-derived coronary artery vasodilator substance in the canine.
Circulation research 1986;58(2):218-29.
1986: Lucchesi B R; Mullane K M
Leukocytes and ischemia-induced myocardial injury.
Annual review of pharmacology and toxicology 1986;26():201-24.
1985: Kopia G A; Eller B T; Patterson E; Shea M J; Lucchesi B R
Antiarrhythmic and electrophysiologic actions of clofilium in experimental canine models.
European journal of pharmacology 1985;116(1-2):49-61.
1985: Lynch J J; Montgomery D G; Ventura A; Lucchesi B R
Antiarrhythmic and electrophysiologic effects of bepridil in chronically infarcted conscious dogs.
The Journal of pharmacology and experimental therapeutics 1985;234(1):72-80.
1985: Schumacher W A; Lee E C; Lucchesi B R
Augmentation of streptokinase-induced thrombolysis by heparin and prostacyclin.
Journal of cardiovascular pharmacology 1985;7(4):739-46.
1985: Werns S W; Shea M J; Driscoll E M; Cohen C; Abrams G D; Pitt B; Lucchesi B R
The independent effects of oxygen radical scavengers on canine infarct size. Reduction by superoxide dismutase but not catalase.
Circulation research 1985;56(6):895-8.
1985: Jolly S R; Schumacher W A; Kunkel S L; Abrams G D; Liddicoat J; Lucchesi B R
Platelet depletion in experimental myocardial infarction.
Basic research in cardiology 1985;80(3):269-79.
1985: Lynch J J; Coskey L A; Montgomery D G; Lucchesi B R
Prevention of ventricular fibrillation by dextrorotatory sotalol in a conscious canine model of sudden coronary death.
American heart journal 1985;109(5 Pt 1):949-58.
1985: Gadsby J E; Keyes P L; Schwartz T S; Bill C H; Lucchesi B
Do catecholamines play a physiologic role in regulating corpus luteum function in the pseudopregnant rabbit?
Biology of reproduction 1985;32(4):907-15.
1985: Lynch J J; Rahwan R G; Lucchesi B R
Antifibrillatory actions of bepridil and butyl-MDI, two intracellular calcium antagonists.
European journal of pharmacology 1985;111(1):9-15.
1985: Gibson J K; Patterson E; Lucchesi B R
The antiarrhythmic actions of intravenous and oral UM424 in postinfarction canine myocardium.
Journal of cardiovascular pharmacology 1985;7(2):211-8.
1985: Wilber D J; Lynch J J; Montgomery D; Lucchesi B R
Postinfarction sudden death: significance of inducible ventricular tachycardia and infarct size in a conscious canine model.
American heart journal 1985;109(1):8-18.
1985: Hook B G; Schumacher W A; Lee D L; Jolly S R; Lucchesi B R
Experimental coronary artery thrombosis in the absence of thromboxane A2 synthesis: evidence for alternate pathways for coronary thrombosis.
Journal of cardiovascular pharmacology 1985;7(1):174-81.
1985: Mitsos S E; Jolly S R; Lucchesi B R
Protective effects of AICAriboside in the globally ischemic isolated cat heart.
Pharmacology 1985;31(3):121-31.
1985: Werns S W; Shea M J; Lucchesi B R
Free radicals in ischemic myocardial injury.
Journal of free radicals in biology & medicine 1985;1(2):103-10.
1985: Jackson C V; Mitsos S E; Simpson P J; Driscoll E M; Lucchesi B R
Effects of bepridil on regional and global myocardial ischemia/reperfusion-induced injury.
Pharmacology 1985;30(6):320-32.
1985: Hess M L; Rowe G T; Caplan M; Romson J L; Lucchesi B
Identification of hydrogen peroxide and hydroxyl radicals as mediators of leukocyte-induced myocardial dysfunction. Limitation of infarct size with neutrophil inhibition and depletion.
Advances in myocardiology 1985;5():159-75.
1984: Schumacher W A; Buda A J; Lucchesi B R
Streptokinase thrombolysis in experimental coronary artery thrombosis: pattern of reflow and effect of a stenosis.
International journal of cardiology 1984;6(5):615-27.
1984: Lynch J J; Wilber D J; Montgomery D G; Hsieh T M; Patterson E; Lucchesi B R
Antiarrhythmic and antifibrillatory actions of the levo- and dextrorotatory isomers of sotalol.
Journal of cardiovascular pharmacology 1984;6(6):1132-41.
1984: Shea M J; Driscoll E M; Romson J L; Pitt B; Lucchesi B R
Effect of OKY-1581, a thromboxane synthetase inhibitor, on coronary thrombosis in the conscious dog.
European journal of pharmacology 1984;105(3-4):285-91.
1984: Patterson E; Montgomery D G; Lynch J J; Lucchesi B R
Cardiac electrophysiologic actions of KB-944 (Fostedil), a new calcium antagonist, in the anesthetized dog.
The Journal of pharmacology and experimental therapeutics 1984;230(3):632-40.
1984: Patterson E; Lynch J J; Lucchesi B R
Antiarrhythmic and antifibrillatory actions of the beta adrenergic receptor antagonist, dl-sotalol.
The Journal of pharmacology and experimental therapeutics 1984;230(2):519-26.
1984: Lucchesi B R
Rationale of therapy in the patient with acute myocardial infarction and life-threatening arrhythmias: a focus on bretylium.
The American journal of cardiology 1984;54(2):14A-19A.
1984: Zimmerman J M; Patterson E; Pitt B; Lucchesi B
Antidysrhythmic actions of meobentine sulfate.
American heart journal 1984;107(6):1117-24.
1984: Shea M J; Murtagh J J; Jolly S R; Abrams G D; Pitt B; Lucchesi B R
Beneficial effects of nafazatrom on ischemic reperfused myocardium.
European journal of pharmacology 1984;102(1):63-70.
1984: Patterson E; Amalfitano D J; Lucchesi B R
Development of ventricular tachyarrhythmias in the conscious canine during the recovery phase of experimental ischemic injury: effect of bethanidine administration.
Journal of cardiovascular pharmacology 1984;6(3):470-5.
1984: Shea M J; Driscoll E M; Romson J L; Pitt B; Lucchesi B R
The beneficial effects of nafazatrom (BAYg6575) on experimental coronary thrombosis.
American heart journal 1984;107(4):629-37.
1984: Jolly S R; Kane W J; Bailie M B; Abrams G D; Lucchesi B R
Canine myocardial reperfusion injury. Its reduction by the combined administration of superoxide dismutase and catalase.
Circulation research 1984;54(3):277-85.
1984: Kirlin P C; Romson J L; Pitt B; Lucchesi B
Regional myocardial contractile response to the beta-adrenergic stimulant prenalterol in the conscious dog following myocardial infarction. Mechanism of hemodynamic effect.
Pharmacology 1984;28(1):51-60.
1984: Patterson E; Lucchesi B R
Antifibrillatory properties of the beta-adrenergic receptor antagonists, nadolol, sotalol, atenolol and propranolol, in the anesthetized dog.
Pharmacology 1984;28(3):121-9.
1983: Schumacher W A; Lucchesi B R
Effect of the thromboxane synthetase inhibitor UK-37,248 (dazoxiben) upon platelet aggregation, coronary artery thrombosis and vascular reactivity.
The Journal of pharmacology and experimental therapeutics 1983;227(3):790-6.
1983: Romson J L; Hook B G; Lucchesi B R
Potentiation of the antithrombotic effect of prostacyclin by simultaneous administration of aminophylline in a canine model of coronary artery thrombosis.
The Journal of pharmacology and experimental therapeutics 1983;227(2):288-94.
1983: Patterson E; Eller B T; Abrams G D; Vasiliades J; Lucchesi B R
Ventricular fibrillation in a conscious canine preparation of sudden coronary death--prevention by short- and long-term amiodarone administration.
Circulation 1983;68(4):857-64.
1983: Patterson E; Lucchesi B R
Antifibrillatory actions of d,l-nadolol in a conscious canine model of sudden coronary death.
Journal of cardiovascular pharmacology 1983;5(5):737-44.
1983: Patterson E; Lucchesi B R
Bretylium: a prototype for future development of antidysrhythmic agents.
American heart journal 1983;106(2):426-31.
1983: Jolly S R; Lucchesi B R
Effect of BW755C in an occlusion-reperfusion model of ischemic myocardial injury.
American heart journal 1983;106(1 Pt 1):8-13.
1983: Pitt B; Shea M J; Romson J L; Lucchesi B R
Prostaglandins and prostaglandin inhibitors in ischemic heart disease.
Annals of internal medicine 1983;99(1):83-92.
1983: Gibson J K; Stewart J R; Li Y P; Lucchesi B R
Electrophysiologic effects of bretylium tosylate on the canine heart during coronary artery occlusion and reperfusion.
Journal of cardiovascular pharmacology 1983;5(4):517-24.
1983: Holland K; Patterson E; Lucchesi B R
Prevention of ventricular fibrillation by bretylium in a conscious canine model of sudden coronary death.
American heart journal 1983;105(5):711-7.
1983: Romson J L; Hook B G; Kunkel S L; Abrams G D; Schork M A; Lucchesi B R
Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog.
Circulation 1983;67(5):1016-23.
1983: Patterson E; Eller B T; Lucchesi B R
Effects of diltiazem upon experimental ventricular dysrhythmias.
The Journal of pharmacology and experimental therapeutics 1983;225(1):224-33.
1983: Eller B T; Patterson E; Lucchesi B R
Ventricular fibrillation in a conscious canine model--its prevention by UM-272.
European journal of pharmacology 1983;87(4):407-13.
1983: Hook B G; Romson J L; Jolly S R; Bailie M B; Lucchesi B R
Effect of zomepirac on experimental coronary artery thrombosis and ischemic myocardial injury in the conscious dog.
Journal of cardiovascular pharmacology 1983;5(2):302-8.
1983: Patterson E; Stetson P; Lucchesi B R
Sublingual absorption of the quaternary ammonium antiarrhythmic agent, UM-272.
Pharmacology 1983;27(4):192-6.
1983: Kopia G A; Driscoll E M; Yeung K F; Lucchesi B R
Antiarrhythmic and cardiovascular actions of the new antibiotic agent pirlimycin adenylate.
Pharmacology 1983;27(5):255-66.
1982: Patterson E; Holland K; Eller B T; Lucchesi B R
Ventricular fibrillation resulting from ischemia at a site remote from previous myocardial infarction. A conscious canine model of sudden coronary death.
The American journal of cardiology 1982;50(6):1414-23.
1982: Romson J L; Hook B G; Rigot V H; Schork M A; Swanson D P; Lucchesi B R
The effect of ibuprofen on accumulation of indium-111-labeled platelets and leukocytes in experimental myocardial infarction.
Circulation 1982;66(5):1002-11.
1982: Patterson E; Gibson J K; Lucchesi B R
Electrophysiologic actions of lidocaine in a canine model of chronic myocardial ischemic damage--arrhythmogenic actions of lidocaine.
Journal of cardiovascular pharmacology 1982;4(6):925-34.
1982: Anderson J L; Brodine W N; Patterson E; Marshall H W; Allison S D; Lucchesi B R
Serial electrophysiologic effects of bretylium in man and their correlation with plasma concentrations.
Journal of cardiovascular pharmacology 1982;4(6):871-82.
1982: Kirlin P C; Romson J L; Pitt B; Abrams G D; Schork M A; Lucchesi B R
Ibuprofen-mediated infarct size reduction: effects on regional myocardial function in canine myocardial infarction in canine myocardial infarction.
The American journal of cardiology 1982;50(4):849-56.
1982: Patterson E; Lucchesi B R
Antifibrillatory actions of nadolol.
The Journal of pharmacology and experimental therapeutics 1982;223(1):144-52.
1982: Anderson J L; Tucker E M; Pasyk S; Patterson E; Simon A B; Burmeister W E; Lucchesi B R; Pitt B
Long-term intravenous infusion of antiarrhythmic drugs using a totally implanted drug delivery system.
The American journal of cardiology 1982;49(8):1954-8.
1982: Colfer H; Stetson P; Lucchesi B R; Wagner J; Pitt B
The nitroglycerin polymer gel matrix system: a new method for administering nitroglycerin evaluated with plasma nitroglycerin levels.
Journal of cardiovascular pharmacology 1982;4(3):521-5.
1982: Jolly S R; Abrams G D; Romson J L; Bailie M B; Lucchesi B R
Effects of lodoxamide on ischemic reperfused myocardium.
Journal of cardiovascular pharmacology 1982;4(3):441-8.
1982: Anderson L C; Fiedler V B; Cohen B J; Anver M R; Simmons J L; Lucchesi B R
Diagnostic exercise.
Laboratory animal science 1982;32(2):141-2.
1982: Bush L R; Romson J L; Ash J L; Lucchesi B R
Effect of diltiazem on extent of ultimate myocardial injury resulting from temporary coronary artery occlusion in dogs.
Journal of cardiovascular pharmacology 1982;4(2):285-96.
1982: Romson J L; Bush L R; Jolly S R; Lucchesi B R
Cardioprotective effects of ibuprofen in experimental regional and global myocardial ischemia.
Journal of cardiovascular pharmacology 1982;4(2):187-96.
1982: Shea M J; Bush L R; Romson J L; Driscoll E M; Lucchesi B R
The effect of diltiazem on coronary thrombosis in the conscious canine.
European journal of pharmacology 1982;77(1):67-70.
1982: Stewart J R; Gibson J K; Lucchesi B R
Effect of infarct size limitation by propranolol on ventricular arrhythmias after myocardial infarction.
Annals of the New York Academy of Sciences 1982;382():223-8.
1982: Kirlin P C; Pitt B; Lucchesi B R
Intravenous prenalterol in acute and chronic heart failure.
Acta medica Scandinavica. Supplementum 1982;659():263-86.
1981: Romson J L; Haack D W; Abrams G D; Lucchesi B R
Prevention of occlusive coronary artery thrombosis by prostacyclin infusion in the dog.
Circulation 1981;64(5):906-14.
1981: Bush L R; Li Y P; Shlafer M; Jolly S R; Lucchesi B R
Protective effects of diltiazem during myocardial ischemia in isolated cat hearts.
The Journal of pharmacology and experimental therapeutics 1981;218(3):653-61.
1981: Kirlin P C; Pitt B; Lucchesi B R
Comparative effects of prenalterol and dobutamine in a canine model of acute ischemic heart failure.
Journal of cardiovascular pharmacology 1981;3(4):896-905.
1981: Patterson E; Lucchesi B R
Chronic ventricular tachyarrhythmias in the conscious dog: prevention by UM-272 (dimethylpropranolol).
Journal of cardiovascular pharmacology 1981;3(4):769-80.
1981: Shlafer M; Kirsh M; Lucchesi B R; Slater A D; Warren S
Mitochondrial function after global cardiac ischemia and reperfusion: influences of organelle isolation protocols.
Basic research in cardiology 1981;76(3):250-66.
1981: Anderson J L; Patterson E; Wagner J G; Johnson T A; Lucchesi B R; Pitt B
Clinical pharmacokinetics of intravenous and oral bretylium tosylate in survivors of ventricular tachycardia or fibrillation: clinical application of a new assay for bretylium.
Journal of cardiovascular pharmacology 1981;3(3):485-99.
1981: Haack D W; Bush L R; Shlafer M; Lucchesi B R
Lanthanum staining of coronary microvascular endothelium: effects of ischemia reperfusion, propranolol, and atenolol.
Microvascular research 1981;21(3):362-76.
1981: Patterson E; Gibson J K; Lucchesi B R
Postmyocardial infarction re-entrant ventricular arrhythmias in conscious dogs: suppression by bretylium tosylate.
The Journal of pharmacology and experimental therapeutics 1981;216(3):453-8.
1981: Bush L R; Warren S; Mesh C L; Lucchesi B R
Comparative effects of aspartate and glutamate during myocardial ischemia.
Pharmacology 1981;23(6):297-304.
1980: Vogel W M; Lucchesi B R
An isolated, blood-perfused, feline heart preparation for evaluating pharmacological interventions during myocardial ischemia.
Journal of pharmacological methods 1980;4(4):291-303.
1980: Patterson E; Gibson J K; Lucchesi B R
Electrophysiologic effects of disopyramide phosphate on reentrant ventricular arrhythmia in conscious dogs after myocardial infarction.
The American journal of cardiology 1980;46(5):792-9.
1980: Romson J L; Bush L R; Haack D W; Lucchesi B R
The beneficial effects of oral ibuprofen on coronary artery thrombosis and myocardial ischemia in the conscious dog.
The Journal of pharmacology and experimental therapeutics 1980;215(1):271-8.
1980: Anderson J L; Patterson E; Conlon M; Pasyk S; Pitt B; Lucchesi B R
Kinetics of antifibrillatory effects of bretylium: correlation with myocardial drug concentrations.
The American journal of cardiology 1980;46(4):583-92.
1980: Anderson J L; Patterson E; Wagner J G; Stewart J R; Behm H L; Lucchesi B R
Oral and intravenous bretylium disposition.
Clinical pharmacology and therapeutics 1980;28(4):468-78.
1980: Bush L R; Haack D W; Shlafer M; Lucchesi B R
Protective effects of beta-adrenergic blockade in isolated ischemic hearts.
European journal of pharmacology 1980;67(2-3):209-17.
1980: Korn N; Gibson J K; Kniffen F J; Lucchesi B R; Ranade V V; Mimnaugh M; Yu T; Counsell R E
Potential organ- or tumor-imaging agents XIX: radioiodinated antiarrhythmic drugs as potential myocardial imaging agents.
Journal of pharmaceutical sciences 1980;69(9):1010-3.
1980: Patterson E; Stetson P; Lucchesi B R
Plasma and myocardial tissue concentrations of UM-272 (N,N-dimethylpropranolol) after oral administration in dogs.
The Journal of pharmacology and experimental therapeutics 1980;214(2):449-53.
1980: Gibson J K; Lucchesi B R
Electrophysiologic actions of UM-272 (Pranolium) on reentrant ventricular arrhythmias in postinfarction canine myocardium.
The Journal of pharmacology and experimental therapeutics 1980;214(2):347-53.
1980: Bush L R; Shlafer M; Haack D W; Lucchesi B R
Time-dependent changes in canine cardiac mitochondrial function and ultrastructure resulting from coronary occlusion and reperfusion.
Basic research in cardiology 1980;75(4):555-71.
1980: Romson J L; Haack D W; Lucchesi B R
Electrical induction of coronary artery thrombosis in the ambulatory canine: a model for in vivo evaluation of anti-thrombotic agents.
Thrombosis research 1980;17(6):841-53.
1980: Vogel W M; Romson J L; Bush L R; Shlafer M; Lucchesi B R
Protective effects of dimethyl-propranolol (UM-272) during global ischemia of isolated feline hearts.
The Journal of pharmacology and experimental therapeutics 1980;212(3):560-8.
1980: Lo K S; Gantz K B; Stetson P L; Lucchesi B R; Pitt B
Disopyramide-induced ventricular tachycardia.
Archives of internal medicine 1980;140(3):413-4.
1980: Patterson E; Stetson P; Lucchesi B R
Sensitive gas chromatographic assay for the quantitation of bretylium in plasma, urine and myocardial tissue.
Journal of chromatography 1980;181(1):33-9.
1980: Stewart J R; Burmeister W E; Burmeister J; Lucchesi B R
Electrophysiologic and antiarrhythmic effects of phentolamine in experimental coronary artery occlusion and reperfusion in the dog.
Journal of cardiovascular pharmacology 1980;2(1):77-91.
1979: Patterson E; Stetson P; Lucchesi B R
Disopyramide plasma and myocardial tissue concentrations as they relate to antiarrhythmic activity.
Journal of cardiovascular pharmacology 1979;1(5):541-50.
1979: Warren S; Lucchesi B R; Shlafer M
Effects of N-dimethyl propranolol (UM-272) on isolated cardiac mitochondria and microsomes.
Research communications in chemical pathology and pharmacology 1979;25(2):227-39.
1979: Ku D D; Lucchesi B R
Ischemic-induced alterations in cardiac sensitivity to digitalis.
European journal of pharmacology 1979;57(2-3):135-47.
1979: Schuster C R; Lucchesi B R; Emley G S
The effects of d-amphetamine, meprobamate, and lobeline on the cigarette smoking behavior of normal human subjects.
NIDA research monograph 1979;(23):91-9.
1979: Vogel W M; Lum D; Lucchesi B R
Methylprednisolone sodium succinate treatment in global ischemia of the cat isolated heart.
Journal of cardiovascular pharmacology 1979;1(1):53-68.
1978: Gibson J K; Burmeister J L; Lucchesi B R
Electrophysiologic effects of UM-272 on myocardial ischemia in the canine heart.
The Journal of pharmacology and experimental therapeutics 1978;207(2):304-10.
1978: Keyes J W; Leonard P F; Brody S L; Svetkoff D J; Rogers W L; Lucchesi B R
Myocardial infarct quantification in the dog by single photon emission computed tomography.
Circulation 1978;58(2):227-32.
1978: Keyes J W; Leonard P F; Svetkoff D J; Brody S L; Rogers W L; Lucchesi B R
Myocardial imaging using emission computed tomography.
Radiology 1978;127(3):809-12.
1978: Peterson A; Lucchesi B; Kirsh M M
The effect of glucagon in animals on chronic propranolol therapy.
The Annals of thoracic surgery 1978;25(4):340-5.
1978: Vogel W M; Lucchesi B R
Methylprednisolone and the size of myocardial infarcts.
Chest 1978;73(4):444.
1978: KU D D; Lucchesi B R
Effects of dimethyl propranolol (UM-272; SC-27761) on myocardial ischemic injury in the canine heart after temporary coronary artery occlusion.
Circulation 1978;57(3):541-8.
1977: Vogel W M; Zannoni V G; Abrams G D; Lucchesi B R
Inability of methylprednisolone sodium succinate to decrease infarct size or preserve enzyme activity measured 24 hours after coronary occlusion in the dog.
Circulation 1977;55(4):588-95.
1976: Lucchesi B R; Burmeister W E; Lomas T E; Abrams G D
Ischemic changes in the canine heart as affected by the dimethyl quaternary analog of propranolol, UM-272 (SC-27761).
The Journal of pharmacology and experimental therapeutics 1976;199(2):310-28.
1976: Argenta L C; Kirsh M M; Bove E L; Cimmino V M; Lucchesi B; Straker J; Baker R; Lee R; Sloan H
A comparison of the hemodynamic effects of inotropic agents.
The Annals of thoracic surgery 1976;22(1):50-7.
1976: Kniffen F J; Winokur S; Counsell R E; Lucchesi B R
The antiarrhythmic and cardiovascular properties of 1-dimethyl isopropylamino-3-(2-phenylphenoxy)-propan-2-ol chloride, UM-424.
The Journal of pharmacology and experimental therapeutics 1976;196(2):420-32.
1975: Lucchesi B R; Kniffen F J
Pharmacological modification of arrhythmias after experimentally induced acute myocardial infarction. Drugs acting on the nervous system.
Circulation 1975;52(6 Suppl):III241-7.
1975: Bookstein J J; Kirsh M M; Prager R L; Lucchesi B R; Dunn J M
Pharmacoangiographic evaluation of the hemodynamic significance of coronary artery stenoses.
Radiology 1975;117(1):5-10.
1975: Kroll D A; Lucchesi B R
Antiarrhythmic and antifibrillatory properties of aprindine.
The Journal of pharmacology and experimental therapeutics 1975;194(2):427-34.
1975: Curtis G P; Setchfield J; Lucchesi B R
The cardiac pharmacology of tolbutamide.
The Journal of pharmacology and experimental therapeutics 1975;194(1):264-73.
1975: Kniffen F J; Lomas T E; Burmeister W E; Lucchesi B R
Effects of dimethyl quaternary propranolol (UM-272) on oxygen consumption and ischemic ST segment changes in the canine heart.
The Journal of pharmacology and experimental therapeutics 1975;194(1):234-43.
1975: Winokur S; Nobel-Allen N L; Lucchesi B R
The positive inotropic effect of glucagon in the chronically failed right ventricle as demonstrated in the isolated cat heart.
European journal of pharmacology 1975;32(02):349-56.
1975: Kniffen F J; Lomas T E; Counsell R E; Lucchesi B R
The antiarrhythmic and antifibrillatory actions of bretylium and its o-iodobenzyl trimethylammonium analog, UM-360.
The Journal of pharmacology and experimental therapeutics 1975;192(1):120-8.
1974: Lucchesi B R
Recent advances in cardiovascular pharmacology.
AANA journal 1974;42(5):419-38.
1974: Nielsen C J; Lucchesi B R
Inability of potassium canrenoate to convert experimentally induced ouabain arrhythmias in the canine heart.
Circulation research 1974;34(5):635-40.
1974: Kniffen F J; Lomas T E; Nobel-Allen N L; Lucchesi B R
The comparative antiarrhythmic actions of lidocaine and its quarternary derivative, methyl lidocaine.
Circulation 1974;49(2):264-71.
1973: Nobel-Allen N; Kirsch M; Lucchesi B R
Glucagon: its enhancement of cardiac performance in the cat with chronic heart failure.
The Journal of pharmacology and experimental therapeutics 1973;187(3):475-81.
1973: Kniffen F J; Schuster D P; Lucchesi B R
Antiarrhythmic and electrophysiologic properties of UM-272, dimethyl quaternary propranolol, in the canine heart.
The Journal of pharmacology and experimental therapeutics 1973;187(2):260-8.
1973: Lucchesi B R; Haley N R
Failure of potassium canrenoate to alter experimentally induced digitalis arrhythmias.
European journal of pharmacology 1973;22(3):256-62.
1973: Schuster D P; Lucchesi B R; Nobel N L; Mimnaugh M N; Counsell R E; Kniffen F J
The antiarrhythmic properties of UM-272, the dimethyl quaternary derivative of propranolol.
The Journal of pharmacology and experimental therapeutics 1973;184(1):213-27.
1972: Lucchesi B R; Medina M; Kniffen F J
The positive inotropic action of insulin in the canine heart.
European journal of pharmacology 1972;18(1):107-15.
1971: Kirsh M M; Kahn D R; Lucchesi B; Gago O; Dufek J H; Lee R W; Stutz D; Sloan H
Effect of glucagon on pulmonary vascular resistance.
Surgery 1971;70(3):439-42.
1971: Lucchesi B R; Hodgeman R J
Effect of 4-(2-hydroxy-3-isopropylaminopropoxy) acetanilide (AY 21,011) on the myocardial and coronary vascular responses to adrenergic stimulation.
The Journal of pharmacology and experimental therapeutics 1971;176(1):200-11.
1970: Antonaccio M J; Lucchesi B R
The interaction of glucagon with theophylline, PGE1, isoproeerenol, ouabain, and CaC1 on the dog isolated papillary muscle.
Life sciences. Pt. 1: Physiology and pharmacology 1970;9(19):1081-9.
1969: Lucchesi B R; Stutz D R; Winfield R A
Glucagon: its enhancement of atrioventricular nodal pacemaker activity and failure to increase ventricular automaticity in dogs.
Circulation research 1969;25(2):183-90.
1969: Stickney J L; Lucchesi B R
The effect of sympatholytic agents on the cardiovascular responses produced by the injection of acetylstrophanthidin into the cerebral ventricles.
European journal of pharmacology 1969;6(1):1-7.
1969: Lucchesi B R; Whitsitt L S
The pharmacology of beta-adrenergic blocking agents.
Progress in cardiovascular diseases 1969;11(5):410-30.
1968: Whitsitt L S; Lucchesi B R
Effects of beta-receptor blockade and glucagon on the atrioventricular transmission system in the dog.
Circulation research 1968;23(5):585-95.
1968: Lucchesi B R; Iwami T
The antiarrhythmic properties of ICI 46037, a quaternary analog of propranolol.
The Journal of pharmacology and experimental therapeutics 1968;162(1):49-59.
1968: Lucchesi B R
Cardiac actions of glucagon.
Circulation research 1968;22(6):777-87.
1968: Emley G S; Schuster C R; Lucchesi B R
Trends observed in the time estimation of three stimulus intervals within and across sessions.
Perceptual and motor skills 1968;26(2):391-8.
1967: Lucchesi B R; Schuster C R; Emley G S
The role of nicotine as a determinant of cigarette smoking frequency in man with observations of certain cardiovascular effects associated with the tobacco alkaloid.
Clinical pharmacology and therapeutics 1967;8(6):789-96.
1967: Whitsitt L S; Lucchesi B R
Effects of propranolol and its stereoisomers upon coronary vascular resistance.
Circulation research 1967;21(3):305-17.
1967: Preston T A; Fletcher R D; Lucchesi B R; Judge R D
Changes in myocardial threshold. Physiologic and pharmacologic factors in patients with implanted pacemakers.
American heart journal 1967;74(2):235-42.
1967: Whitsitt L S; Lucchesi B R
The cardiac beta-adrenergic receptor blocking actions of propranolol and its stereoisomers.
Life sciences 1967;6(9):939-50.
1967: Lucchesi B R; Whitsitt L S; Stickney J L
Antiarrhythmic effects of beta adrenergic blocking agents.
Annals of the New York Academy of Sciences 1967;139(3):940-51.
1966: Lucchesi B R; Whitsitt L S; Brown N L
Propranolol (Inderal) in experimentally-induced cardiac arrhythmias.
Canadian journal of physiology and pharmacology 1966;44(4):543-7.
1966: Preston T A; Judge R D; Lucchesi B R; Bowers D L
Myocardial threshold in patients with artificial pacemakers.
The American journal of cardiology 1966;18(1):83-9.
1965: LUCCHESI B R
THE EFFECTS OF PRONETHALOL AND ITS DEXTRO ISOMER UPON EXPERIMENTAL CARDIAC ARRHYTHMIAS.
The Journal of pharmacology and experimental therapeutics 1965;148():94-9.
1964: LUCCHESI B R
THE ACTION OF NETHALIDE UPON EXPERIMENTALLY INDUCED CARDIAC ARRHYTHMIAS.
The Journal of pharmacology and experimental therapeutics 1964;145():286-91.
1964: LUCCHESI B R; SHIVAK R
EFFECT OF QUINIDINE AND PROCAINE AMIDE UPON ACETYLSTROPHANTHIDIN CARDIOTOXICITY.
The Journal of pharmacology and experimental therapeutics 1964;143():367.
1962: LUCCHESI B R
The action of dichloroisoproterenol (DCI) and several other pharmacological agents upon the aconitine-induced ventricular arrhythmia in the isolated rabbit heart.
The Journal of pharmacology and experimental therapeutics 1962;137():291-300.
1961: LUCCHESI B R; HARDMAN H F
The influence of dichloroiso-proterenol (DCI) and related compounds upon ouabain and acetylstrophanthidin induced cardiac arrhythmias.
The Journal of pharmacology and experimental therapeutics 1961;132():372-81.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Benedict Lucchesi

Research Profile (preview)

Living Beings

Disorders

Physiology

Anatomy

Chemicals & Drugs

Devices

Concepts & Ideas

Procedures

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Benedict Lucchesi (preview)

All Publications